Nasal Influenza Vaccine
Learn how Quintiles was able to recruit 3200 patients in 14 days for a Phase III nasal influenza vaccine study in Argentina, Brazil and South Africa.
Learn how Quintiles was able to recruit 3200 patients in 14 days for a Phase III nasal influenza vaccine study in Argentina, Brazil and South Africa.